Targeting of cancer cells with monoclonal antibodies specific for C3b(i)
Mitchell H. Sokoloff(University of Virginia), Ronald P. Taylor(University of Virginia), Alexander J. Bankovich(AbbVie (United States)), Alessandra Nardin(Singapore Immunology Network), Margaret A. Lindorfer(University of Virginia), William Sutherland(University of Virginia), Michael D. Solga(University of Virginia Health System), Haiyen E. Zhau(Cedars-Sinai Medical Center), Leland W.K. Chung(VA Palo Alto Health Care System)
Cited by 12
Related Papers
Androgen-independent cancer progression and bone metastasis in the LNCaP model of human prostate cancer.
|PubMed|1994|739
Highly Efficient Capture of Circulating Tumor Cells by Using Nanostructured Silicon Substrates with Integrated Chaotic Micromixers
|Angewandte Chemie International Edition|2011|618
Bioconjugated quantum dots for multiplexed and quantitative immunohistochemistry
|Nature Protocols|2007|520
Insulin-like Growth Factor-I–Dependent Up-regulation of ZEB1 Drives Epithelial-to-Mesenchymal Transition in Human Prostate Cancer Cells
|Cancer Research|2008|384
MOLECULAR INSIGHTS INTO PROSTATE CANCER PROGRESSION: THE MISSING LINK OF TUMOR MICROENVIRONMENT
|The Journal of Urology|2005|363